JS-214

N/A

Report date: 2025/09/16 16:09:26

Base Information

Drug NameJS-214
Drug Alias NameJS-214JS214
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor modulatorsTGF-β pathway modulators
TargetsVascular endothelial growth factorTransforming growth factor beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Junshi Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Junshi Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A